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as previously described. 1 For 2-D difference gel electrophoresis (2-D DIGE), the proteins were labelled with fluorescent cyanine dyes (GE Healthcare, Milwaukee, Wisconsin, USA) following the manufacturer's instructions. In brief, 50 mg of extracted protein to be compared was labelled with 400 pmol Cy3 or Cy5, while 400 pmol Cy2 was employed to label 50 mg of internal standard protein of each sample at an equal amount. The labelling was performed on ice in the dark for 30 min, and then quenched with 1 ml of 10 mM lysine (Sigma) for 10 min. A 50 mg aliquot of Cy3and Cy5-labelled samples was combined before mixing with 50 mg of Cy2-labelled internal standard. The 2× sample buffer with an equal volume (8 M urea, 2 M thiourea, 4% CHAPS, 2% Bio-lyte, pH 4-7, 130 mM dithiothreitol (DTT)) was added to the sample, and the final volume was adjusted to 450 ml with rehydration buffer (8 M urea, 4% CHAPS, 1% Biolyte, pH 4e7, 40 mM DTT). The proteins were applied to IPG (immobilised pH gradient) strips (pH 4-7, 24 cm) and focused on an IPGphor (GE Healthcare). Focused IPG strips were equilibrated, and then loaded onto 12% SDS-polyacrylamide gels (SDS-PAGE) using low-fluorescence glass plates on an Ettan DALT II system (GE Healthcare). All electrophoresis procedures were performed in the dark. The biological triplicates were run on three gels as analytical gels. In addition, another strip was performed in parallel as a preparative gel for picking spots as described in 2-D DIGE, except that the IPG strip was loaded with 1000 mg of proteins, and the gel was stained with Coomassie brilliant blue. After SDS-PAGE, the three analytical gels were scanned with a Typhoon 9410 scanner (GE Healthcare) with appropriate excitation/emission wavelengths specific for Cy2 Student t test p values for the variance of these ratios for each protein pair across all samples. The differential protein spots (|ratio|>2, P<0.05) which were altered consistently in all three protein spot maps were selected for further identification.
Immunohistochemistry (IHC)
Immunohistochemistry was performed, as previously described 2 , to investigate the localization and expression of 14-3-3σ and LASP1 in 116 human CRC tissues.
The sections were incubated with primary antibodies against 14-3-3σ (1:200; Sigma) and LASP1 (1:100; Millipore) overnight at 4 o C. Mayer's haematoxylin was used for nuclear counterstaining. The sections were mounted with a synthetic medium. The slides were reviewed by two or three pathologists blind to the study. To evaluate 14-3-3σ and LASP1 expression levels, immunostained slides were evaluated using a method described previously 2, 3 . Scores representing the percentage of positive cells were as follows: 0% (absent), 1-5% (sporadic), 6-25% (local), 26-50% (occasional), 51-75% (majority) and 76-100% (large majority). Intensity of staining of cancer cells was scored as 0 (no staining), 1 (weak staining, light yellow), 2 (moderate staining, yellowish brown), and 3 (strong staining, brown). An intensity score of ≥ 2 with at least 50% of positive cells was considered as having high expression (or over-expression), and <50% of positive cells or < 2 in intensity score was regarded as low expression. The discrepancies (< 5%) were resolved by simultaneous re-evaluation. 
Cell migration analysis

Plasmid constructs
All eukaryotic expression vectors were constructed in pEX-3 (pGCMV/MCS/Neo). Generation of 14-3-3σ was achieved by using oligonucleotides in-frame to amino-terminus of pEX-3 template by standard PCR techniques (Shanghai GenePharma Co., Shanghai, China). The coding sequence for the constructs was verified by sequencing analysis.
siRNA-mediated gene silencing
Expression of human 14-3-3σ and LASP1 was knocked down with siRNA duplexes targeting the sequence. The siRNAs were designed and chemically synthesized (Shanghai GenePharma Co., Shanghai, China) for targeting different coding regions of the genes. The negative control siRNA targeting unknown mRNA sequence was used as a control. The sequences used are shown in Table S2 (see supplementary material). Both siRNAs were synthesized from GenePharma (Shanghai, China). A BLAST search of the human genome verified that the selected sequences were specific for the target genes. Exponential growth phase cells were plated in 6-well plates at a density of 0.5×10 5 cells/ml, cultured for 24 h and transfected with 1 μg siRNA in reduced serum medium (OPTI-MEM-I) according to the manufacturer's protocol in 30-50% confluence. Fluorescein (FAM)-labeled negative control siRNA was used to visualize the transfection efficiency.
Co-immunoprecipitation (Co-IP)
The cells were transiently or stably transfected with the indicated constructs.
Cells were harvested and lysed in 1 ml of lysis buffer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40). Resulting lysates were subjected to immunoprecipitation with antibodies directed to the epitope tag. Immunoprecipitates were washed in lysis buffer, resolved by SDS-polyacrylamide gel electrophoresis, and subsequently analyzed by mass spectrum or protein immunoblotting.
Digestion of Proteins and Identification by Matrix-assisted Laser
Desorption/ionization Time of Flight Mass Spectrometry
The identified protein bands in the gel were excised from the gel and were in-gel digested. Briefly, the gel bands were destained in 30 mmol/L K 3 Fe(CN) 6 Figure S1, related to Figure 1 . The effect of LASP1 expression on 14-3-3σ mRNA
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